e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study
Bathoorn E., Slebos D-J., Postma D. S., Koeter G. H., van Oosterhout A. J. M., van der Toorn M., Boezen H. M., Kerstjens H. A. M.
Source:
Eur Respir J 2007; 30: 1131-1137
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bathoorn E., Slebos D-J., Postma D. S., Koeter G. H., van Oosterhout A. J. M., van der Toorn M., Boezen H. M., Kerstjens H. A. M.. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J 2007; 30: 1131-1137
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib
Source: International Congress 2016 – IPF treatment II
Year: 2016
Comparative study of hospitalized patients with acute exacerbation of COPD with and without carbon dioxide retention
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Effects of low dose inhaled carbon monoxide in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 661s
Year: 2006
Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary disease
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
The importance of measuriing exhaled carbon monoxide in asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003
The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006
Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis
Source: Eur Respir J 2002; 20: 92-99
Year: 2002
Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH)
Source: Eur Respir J 2001; 18: Suppl. 33, 83s
Year: 2001
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Source: Eur Respir J 2006; 27: 964-971
Year: 2006
Exhaled carbon monoxide correlates with airway neutrophilia in patients with chronic allograft dysfunction (BOS) after lung transplantation
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007
Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD
Source: Annual Congress 2012 - Tobacco dependence and respiratory disease
Year: 2012
Relationship between diffusing capacity for carbon monoxide and severity of airway obstruction, presence of cor pulmonale chronic in obese and nonobese stable COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 726s
Year: 2006
Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD)
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001
Monitoring exhaled carbon monoxide in COPD exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
The influence of statin supplementation on inflammatory markers in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept